Literature DB >> 20188998

Prolotherapy in primary care practice.

David Rabago1, Andrew Slattengren, Aleksandra Zgierska.   

Abstract

Prolotherapy is an injection-based complementary and alternative medical therapy for chronic musculoskeletal pain. Prolotherapy techniques and injected solutions vary by condition, clinical severity, and practitioner preferences; over several treatment sessions, a fairly small volume of an irritant or sclerosing solution is injected at sites on painful ligament and tendon insertions and in adjacent joint space during several treatment sessions. Prolotherapy is becoming increasingly popular in the United States and internationally and is actively used in clinical practice. Prolotherapy has been assessed as a treatment for various painful chronic musculoskeletal conditions that are refractory to "standard of care" therapies. Although anecdotal clinical success guides the use of prolotherapy for many conditions, clinical trial literature supporting evidence-based decision-making for the use of prolotherapy exists for low back pain, several tendinopathies, and osteoarthritis. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20188998      PMCID: PMC2831229          DOI: 10.1016/j.pop.2009.09.013

Source DB:  PubMed          Journal:  Prim Care        ISSN: 0095-4543            Impact factor:   2.907


  65 in total

Review 1.  Clinical practice. Plantar fasciitis.

Authors:  Rachelle Buchbinder
Journal:  N Engl J Med       Date:  2004-05-20       Impact factor: 91.245

2.  Re: Yelland MJ, Glasziou PP, Bogduk N, et al. Prolotherapy injections, saline injections, and exercises for chronic low-back pain: a randomized study. Spine. 2003;29:9-16.

Authors:  K Dean Reeves; Robert G Klein; W Bradford DeLong
Journal:  Spine (Phila Pa 1976)       Date:  2004-08-15       Impact factor: 3.468

3.  Side effects and adverse events related to intraligamentous injection of sclerosing solutions (prolotherapy) for back and neck pain: A survey of practitioners.

Authors:  Simon Dagenais; Oladele Ogunseitan; Scott Haldeman; James R Wooley; Robert L Newcomb
Journal:  Arch Phys Med Rehabil       Date:  2006-07       Impact factor: 3.966

4.  A classification of Achilles tendon disease.

Authors:  G Puddu; E Ippolito; F Postacchini
Journal:  Am J Sports Med       Date:  1976 Jul-Aug       Impact factor: 6.202

5.  An in situ study of the influence of a sclerosing solution in rabbit medial collateral ligaments and its junction strength.

Authors:  Y K Liu; C M Tipton; R D Matthes; T G Bedford; J A Maynard; H C Walmer
Journal:  Connect Tissue Res       Date:  1983       Impact factor: 3.417

6.  A two-year sonographic follow-up after intratendinous injection therapy in patients with tennis elbow.

Authors:  E Zeisig; M Fahlström; L Ohberg; H Alfredson
Journal:  Br J Sports Med       Date:  2008-07-29       Impact factor: 13.800

7.  The etiology and conservative treatment of humeral epicondylitis.

Authors:  P Kivi
Journal:  Scand J Rehabil Med       Date:  1983

Review 8.  Prolotherapy injections for chronic low back pain: a systematic review.

Authors:  Michael J Yelland; Christopher Del Mar; Sandi Pirozzo; Mark L Schoene
Journal:  Spine (Phila Pa 1976)       Date:  2004-10-01       Impact factor: 3.468

9.  The use of prolotherapy in the sacroiliac joint.

Authors:  M Cusi; J Saunders; B Hungerford; T Wisbey-Roth; P Lucas; S Wilson
Journal:  Br J Sports Med       Date:  2008-04-09       Impact factor: 13.800

10.  Extensor origin vascularity related to pain in patients with Tennis elbow.

Authors:  Eva Zeisig; Lars Ohberg; Håkan Alfredson
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2006-03-23       Impact factor: 4.342

View more
  46 in total

Review 1.  Proliferative injection therapy for osteoarthritis: a systematic review.

Authors:  Mišo Krstičević; Milka Jerić; Svjetlana Došenović; Antonia Jeličić Kadić; Livia Puljak
Journal:  Int Orthop       Date:  2017-02-11       Impact factor: 3.075

2.  Dextrose and morrhuate sodium injections (prolotherapy) for knee osteoarthritis: a prospective open-label trial.

Authors:  David Rabago; Jeffrey J Patterson; Marlon Mundt; Aleksandra Zgierska; Luke Fortney; Jessica Grettie; Richard Kijowski
Journal:  J Altern Complement Med       Date:  2014-03-17       Impact factor: 2.579

3.  PURLs: Prolotherapy: a nontraditional approach to knee osteoarthritis.

Authors:  Andrew H Slattengren; Trent Christensen; Shailendra Prasad; Kohar Jones
Journal:  J Fam Pract       Date:  2014-04       Impact factor: 0.493

4.  Dextrose injections for failed back surgery syndrome: a consecutive case series.

Authors:  İlker Solmaz; Serkan Akpancar; Aydan Örsçelik; Özlem Yener-Karasimav; Deniz Gül
Journal:  Eur Spine J       Date:  2019-05-21       Impact factor: 3.134

5.  Therapeutic effects of prolotherapy with intra-articular dextrose injection in patients with moderate knee osteoarthritis: a single-arm study with 6 months follow up.

Authors:  Fariba Eslamian; Bahman Amouzandeh
Journal:  Ther Adv Musculoskelet Dis       Date:  2015-04       Impact factor: 5.346

Review 6.  Prolotherapy: Potential for the Treatment of Chronic Wounds?

Authors:  Amir Hossein Siadat; Roslyn Rivkah Isseroff
Journal:  Adv Wound Care (New Rochelle)       Date:  2019-04-03       Impact factor: 4.730

7.  Hypertonic dextrose and morrhuate sodium injections (prolotherapy) for lateral epicondylosis (tennis elbow): results of a single-blind, pilot-level, randomized controlled trial.

Authors:  David Rabago; Ken S Lee; Michael Ryan; Amrish O Chourasia; Mary E Sesto; Aleksandra Zgierska; Rick Kijowski; Jessica Grettie; John Wilson; Daniel Miller
Journal:  Am J Phys Med Rehabil       Date:  2013-07       Impact factor: 2.159

8.  Association between disease-specific quality of life and magnetic resonance imaging outcomes in a clinical trial of prolotherapy for knee osteoarthritis.

Authors:  David Rabago; Richard Kijowski; Michael Woods; Jeffrey J Patterson; Marlon Mundt; Aleksandra Zgierska; Jessica Grettie; John Lyftogt; Luke Fortney
Journal:  Arch Phys Med Rehabil       Date:  2013-07-10       Impact factor: 3.966

9.  Qualitative Assessment of Patients Receiving Prolotherapy for Knee Osteoarthritis in a Multimethod Study.

Authors:  David Rabago; Laura van Leuven; Lane Benes; Luke Fortney; Andrew Slattengren; Jessica Grettie; Marlon Mundt
Journal:  J Altern Complement Med       Date:  2016-09-07       Impact factor: 2.579

10.  Dextrose prolotherapy for knee osteoarthritis: a randomized controlled trial.

Authors:  David Rabago; Jeffrey J Patterson; Marlon Mundt; Richard Kijowski; Jessica Grettie; Neil A Segal; Aleksandra Zgierska
Journal:  Ann Fam Med       Date:  2013 May-Jun       Impact factor: 5.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.